sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Hemophilia Treatment Market Scope And Analysis

  • Report Code : TIPRE00008241
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Hemophilia Treatment Market Analysis and Scope (2021-2031)

Buy Now

Hemophilia Treatment Market Report Hemophilia Treatment Market Size and Share Hemophilia Treatment Market Scope and Analysis

Hemophilia Treatment Market Report Scope

Report Attribute Details
Market size in 2021 US$ 14.44 Billion
Market Size by 2031 US$ 23.53 Billion
Global CAGR (2023 - 2031) 5.1%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product
  • Plasma Derived Coagulation Factor Concentrates
  • Recombinant Coagulation Factor Concentrates
  • Desmopressin
  • Antifibrinolytic Agents
By Disease
  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
By Treatment Type
  • On-demand
  • Prophylaxis
By Therapy
  • Replacement Therapy
  • ITI Therapy
  • Gene Therapy
  • Antibody Therapy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bayer AG
  • Sanofi
  • F Hoffmann la Roche Ltd
  • Kedrion S P A
  • CSL Limited
  • Biotest AG
  • Pfizer Inc
  • Novo Nordisk A S
  • Octapharma AG
  • Baxter International Inc